Georgina Gener-Ricos

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 11

Top Venues

Leukemia & lymphoma

Blood advances

Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Georgina Gener-Ricos, Juan José Rodríguez Sevilla, Samuel Urrutia, Alex Bataller, Alexandre Bazinet, Guillermo Garcia-Manero
Advances in the management of higher-risk myelodysplastic syndromes: future prospects. Leukemia & lymphoma 65 (9) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Georgina Gener-Ricos, Juan José Rodríguez Sevilla, Samuel Urrutia, Alex Bataller, Alexandre Bazinet, Guillermo Garcia-Manero
Advances in the management of higher-risk myelodysplastic syndromes: future prospects. Leukemia & lymphoma (2024)
Georgina Gener-Ricos, Juan José Rodríguez Sevilla, Samuel Urrutia, Alex Bataller, Alexandre Bazinet, Guillermo Garcia-Manero
Advances in the management of higher-risk myelodysplastic syndromes: future prospects. Leukemia & lymphoma 65 (9) (2024)
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, Kelly Sharon Chien, Andres E Quesada, Emmanuel Almanza-Huante, Danielle Hammond, Koiji Sasaki, Courtney D D DiNardo, Tapan Mahendra Kadia, Naval G Daver, Gautam Borthakur, Ghayas C Issa, Nicholas James Short, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage. Cancer (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Koji Sasaki, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances (2024)

Georgina Gener-Ricos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Georgina Gener-Ricos